S.African scientist: Data show J&J vaccine works well vs Delta variant | Inquirer News
Close  

S.African scientist: Data show J&J vaccine works well vs Delta variant

/ 02:40 PM July 02, 2021
A box of Johnson & Johnson's COVID-19 vaccines is seen at the Forem vaccination centre in Pamplona

FILE PHOTO: A box of Johnson & Johnson’s coronavirus disease (COVID-19) vaccines is seen at the Forem vaccination center in Pamplona, Spain, April 22, 2021. REUTERS/Vincent West/File Photo

JOHANNESBURG — Data from laboratory studies show Johnson & Johnson’s COVID-19 vaccine works well against the Delta variant that now dominates new infections in South Africa, the head of the country’s Medical Research Council said on Friday.

“All the data that we see indicate good immediate and sustained immune response against Delta, and we see surprising durability in the immune response for the single dose J&J right up to eight months,” Glenda Gray told a news conference.

ADVERTISEMENT

South Africa is using the J&J and Pfizer vaccines in its immunization campaign.

FEATURED STORIES

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

For more news about the novel coronavirus click here.
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.

The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link .

Read Next
Don't miss out on the latest news and information.

Subscribe to INQUIRER PLUS to get access to The Philippine Daily Inquirer & other 70+ titles, share up to 5 gadgets, listen to the news, download as early as 4am & share articles on social media. Call 896 6000.

TAGS: coronavirus pandemic, coronavirus vaccine, Delta variant, Johnson & Johnson, South Africa
For feedback, complaints, or inquiries, contact us.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and
acknowledge that I have read the Privacy Policy.



© Copyright 1997-2022 INQUIRER.net | All Rights Reserved

We use cookies to ensure you get the best experience on our website. By continuing, you are agreeing to our use of cookies. To find out more, please click this link.